Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Akebia Therapeutics (AKBA) Long-Term Debt Issuances (2024 - 2025)

Akebia Therapeutics has reported Long-Term Debt Issuances over the past 2 years, most recently at $10.0 million for Q1 2025.

Quarterly Long-Term Debt Issuances fell 72.97% to $10.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Dec 2025, down 77.78% year-over-year, with the annual reading at $10.0 million for FY2025, 77.78% down from the prior year.
Long-Term Debt Issuances was $10.0 million for Q1 2025 at Akebia Therapeutics, up from $8.0 million in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $37.0 million in Q1 2024 and troughed at $8.0 million in Q2 2024.